Our data indicated that MCP-1 containing or glioma-conditioned media—the later theoretically full of MCP-1 and other chemokines—significantly enhanced T cell migration suggesting that targeting of remote tumor cells is possible. The gene discussed is CCL2; the disease is glioma.